Search results
Results: 39
Number of items: 39
-
van Amerongen, R., Bentires-Alj, M., van Boxtel, A. L., Clarke, R. B., Fre, S., Suarez, E. G., Iggo, R., Jechlinger, M., Jonkers, J., Mikkola, M. L., Koledova, Z. S., Sørlie, T., & Vivanco, M. DM. (2023). Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research. Journal of Mammary Gland Biology and Neoplasia, 28(1), Article 17. https://doi.org/10.1007/s10911-023-09544-y -
van Amerongen, R., Kordon, E. C., & Koledova, Z. (2021). Connecting the Dots: Mammary Gland and Breast Cancer at Single Cell Resolution. Journal of Mammary Gland Biology and Neoplasia, 26(1), 1-2. https://doi.org/10.1007/s10911-021-09492-5
-
van Amerongen, R. (2021). Behind the Scenes of the Human Breast Cell Atlas Project. Journal of Mammary Gland Biology and Neoplasia, 26(1), 67-70. https://doi.org/10.1007/s10911-021-09482-7 -
de Man, S. M. A., Zwanenburg, G., van der Wal, T., Hink, M. A., & van Amerongen, R. (2021). Quantitative live-cell imaging and computational modelling shed new light on endogenous WNT/CTNNB1 signaling dynamics. eLife, 10, Article e66440. https://doi.org/10.7554/eLife.66440 -
de Man, S. M. A., & van Amerongen, R. (2021). Zooming in on the WNT/CTNNB1 Destruction Complex: Functional Mechanistic Details with Implications for Therapeutic Targeting. In G. Schulte, & P. Kozielewicz (Eds.), Pharmacology of the WNT Signaling System (pp. 137-173). (Handbook of experimental pharmacology; Vol. 269). Springer. https://doi.org/10.1007/164_2021_522 -
van der Wal, T., Lambooij, J.-P., & van Amerongen, R. (2020). TMEM98 is a negative regulator of FRAT mediated Wnt/ß-catenin signalling. PLoS ONE, 15(1), Article e0227435. https://doi.org/10.1371/journal.pone.0227435 -
van der Wal, T., & van Amerongen, R. (2020). Walking the tight wire between cell adhesion and WNT signalling: A balancing act for β-catenin. Open Biology, 10(12), Article 200267. https://doi.org/10.1098/rsob.200267 -
van Schie, E. H., & van Amerongen, R. (2020). Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence. Frontiers in cell and developmental biology, 8, Article 25. https://doi.org/10.3389/fcell.2020.00025
Page 2 of 4